Dn B Asset Management As Apellis Pharmaceuticals, Inc. Transaction History
Dn B Asset Management As
- $19.9 Billion
- Q2 2024
A detailed history of Dn B Asset Management As transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 7,972 shares of APLS stock, worth $299,986. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,972
Previous 6,068
31.38%
Holding current value
$299,986
Previous $356,000
14.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$617 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$437 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$418 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$369 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$218 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.13B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...